Glaucoma Today

10/23/2025

In this special supplement to Glaucoma Today, leaders from Iantrek, PLU Ophthalmics, and more, spotlight some of the most exciting developments redefining the future of ophthalmology and the way clinicians will diagnose, treat, and care for patients.

See more here: https://ow.ly/3JTN50Xh3BM

10/22/2025

Recognize familiar scenarios?

Our latest article, 'A Day in the Life: Glaucoma Specialists and Faculty,' provides an authentic glimpse into the clinical and academic worlds of those shaping the future of glaucoma.

A valuable read for understanding diverse approaches and shared challenges in the field: https://ow.ly/Z9mZ50Xgwtg

10/21/2025

New research shows that lens status — whether the eye is phakic, pseudophakic, or undergoing cataract surgery — doesn’t significantly affect the success of glaucoma drainage devices. 👁️

These findings offer valuable insight for surgeons weighing timing and surgical strategy, reinforcing confidence in GDD outcomes across patient types.

Read more in the latest issue of Glaucoma Today:

Two studies evaluated success rates and factors.

10/20/2025

Implementing standalone MIGS in practice. Dr. Jai Parekh shares how the OMNI® Surgical System by Sight Sciences supports primary open-angle glaucoma care and helps address unmet clinical needs with innovative technology: https://ow.ly/E8x150Xf3QJ

Visit https://ow.ly/Sgxp50Xf3QM to see the indications for use, contraindications, warnings, and potential adverse events.

10/16/2025

Dr. Marjan Farid discusses the side effect profile associated with 0.4% pilocarpine ophthalmic solution (Qlosi, Orasis) in this clip from a recent episode of Innovation Journal Club. Watch the full episode here: https://ow.ly/U6uX50Xcsu9

10/15/2025

See Mitosol full prescribing information at https://mitosol.com/mitosol-package-insert/

See Amphadase full prescribing information athttp://eyeamphadase.com/wp-content/uploads/2017/05/amphadase-product-insert.pdf

10/13/2025

"In this issue of GT, we hear from surgeons who changed their thinking in recent years, sometimes pivoting from approaches that had been in use throughout their careers.

As new evidence and personal experience build, the best dogma might be to not be so dogmatic. Maybe some practices that were once considered harmful could be effective under the right conditions.

As we continue to expand our knowledge of and options for managing glaucoma surgically, open dialogue about how and why our perspectives evolve is essential to our continued progress" - Chief Medical Editor Arsham Sheybani, MD.

Continue on at GlaucomaToday.com

10/10/2025

Check out the newest issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, presented by Dr. Robert Osher: https://ow.ly/BI2W50X9XZt

10/07/2025

Read this article to gain expert insights into the complementary roles of SLT and sustained-release drug delivery in early-stage glaucoma management: https://ow.ly/iSL450X81NH The Fundingsland Group

10/06/2025

[SURVEY SAYS] I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS.

Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is.

Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience: https://ow.ly/t8z150X7bKZ

10/02/2025

How do we expand options for patients with glaucoma? In this upcoming webinar, leading surgeons will share how a bio-interventional surgical approach can transform outcomes by enhancing the uveoscleral pathway.

📅 Don’t miss it—secure your spot now! https://ow.ly/VYMa50X5G78

09/26/2025

Watch the latest episode of Glaucoma Case Files as Drs. Simpson and Garakani discuss a patient’s complicated surgical history for neovascular glaucoma, and how they managed the patient’s IOP and pain symptoms with ECP and other strategies. Watch here: https://ow.ly/Eurg50WXJHm